BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX)
CUSIP: 09075V102
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
- Shares outstanding
- 239,647,920
- Total 13F shares
- 6,620,182
- Share change
- -1,866,579
- Total reported value
- $383,744,138
- Price per share
- $58.40
- Number of holders
- 36
- Value change
- -$108,916,451
- Number of buys
- 23
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP 09075V102?
CUSIP 09075V102 identifies BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09075V102:
Top shareholders of BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Artal Group S.A. |
13F
|
Company |
1.1%
|
2,628,130
|
$89,041,000 | — | 31 Dec 2019 | |
| FMR LLC |
13F
|
Company |
0.95%
|
2,285,219
|
$77,424,000 | — | 31 Dec 2019 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.89%
|
2,128,182
|
$72,103,000 | — | 31 Dec 2019 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.2%
|
469,566
|
$14,189,000 | — | 31 Dec 2019 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.12%
|
277,000
|
$9,462,000 | — | 31 Dec 2019 | |
| Redmile Group, LLC |
13F
|
Company |
0.07%
|
173,500
|
$5,878,000 | — | 31 Dec 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.06%
|
140,205
|
$4,750,000 | — | 31 Dec 2019 | |
| Laurion Capital Management LP |
13F
|
Company |
0.06%
|
138,200
|
$4,682,000 | — | 31 Dec 2019 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.04%
|
92,796
|
$3,144,000 | — | 31 Dec 2019 | |
| Vident Investment Advisory, LLC |
13F
|
Company |
0.02%
|
51,917
|
$1,759,000 | — | 31 Dec 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
35,000
|
$1,185,000 | — | 31 Dec 2019 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.01%
|
25,150
|
$852,000 | — | 31 Dec 2019 | |
| Point72 Hong Kong Ltd |
13F
|
Company |
0.01%
|
17,498
|
$593,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
10,872
|
$368,000 | — | 31 Dec 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,321
|
$44,000 | — | 31 Dec 2019 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,050
|
$36,000 | — | 31 Dec 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,000
|
$34,000 | — | 31 Dec 2019 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
80
|
$3,000 | — | 31 Dec 2019 | |
| QCI ASSET MANAGEMENT INC/NY |
13F
|
Company |
0%
|
75
|
$3,000 | — | 31 Dec 2019 |
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q1 2020
As of 31 Mar 2020,
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,620,182 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, Artal Group S.A., FMR LLC, PLATINUM INVESTMENT MANAGEMENT LTD, Redmile Group, LLC, DekaBank Deutsche Girozentrale, SCHRODER INVESTMENT MANAGEMENT GROUP, Vident Investment Advisory, LLC, Avitas Wealth Management LLC, and DEUTSCHE BANK AG\.
This page lists
36
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
19
Q1 2020 holders
36
Holder diff
17
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.